We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-1.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$54B
AUM Growth
-$3.2B
Cap. Flow
-$865M
Cap. Flow %
-1.6%
Top 10 Hldgs %
28.71%
Holding
986
New
116
Increased
314
Reduced
359
Closed
149

Top Buys

Rank Stock Value
1
HUBB icon
Hubbell
HUBB
+$244M
2
NSC icon
Norfolk Southern
NSC
+$149M
3
INSM icon
Insmed
INSM
+$138M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$131M
5
DHR icon
Danaher
DHR
+$119M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$340M
2
BMY icon
Bristol-Myers Squibb
BMY
+$339M
3
UNP icon
Union Pacific
UNP
+$191M
4
MCD icon
McDonald's
MCD
+$190M
5
HES
Hess
HES
+$168M

Sector Composition

Rank Sector Weight
1 Technology 26.3%
2 Healthcare 14.99%
3 Financials 12.56%
4 Consumer Discretionary 9.54%
5 Industrials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VICI icon
276
VICI Properties
VICI
$29.2B
$39.5M 0.07%
1,212,100
-512,300
-30% -$15.8M
ITCI
277
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$39.4M 0.07%
298,391
-379,609
-56% -$47.3M
FICO icon
278
Fair Isaac
FICO
$22.3B
$39.3M 0.07%
21,300
-1,500
-7% -$2.78M
CNC icon
279
Centene
CNC
$31.7B
$39.2M 0.07%
646,228
+174,516
+37% +$10.5M
HSIC icon
280
Henry Schein
HSIC
$9.83B
$39.2M 0.07%
572,455
+82,142
+17% +$6.07M
TVTX icon
281
Travere Therapeutics
TVTX
$5.89B
$39.2M 0.07%
2,184,898
+1,808,098
+480% +$36.7M
HCC icon
282
Warrior Met Coal
HCC
$4.73B
$39.1M 0.07%
820,000
+660,000
+413% +$33.7M
AMCR icon
283
Amcor
AMCR
$21.8B
$39M 0.07%
803,818
+441,549
+122% +$21.8M
ROIV icon
284
Roivant Sciences
ROIV
$25.4B
$38.5M 0.07%
3,819,983
-1,900,000
-33% -$20.5M
VST icon
285
Vistra
VST
$47.7B
$38.5M 0.07%
328,000
-129,900
-28% -$19.4M
ADSK icon
286
Autodesk
ADSK
$51.2B
$38.3M 0.07%
146,189
-34,700
-19% -$9.87M
MGTX icon
287
MeiraGTx Holdings
MGTX
$1.18B
$38.2M 0.07%
5,634,578
+600,000
+12% +$4.03M
OCUL icon
288
Ocular Therapeutix
OCUL
$1.92B
$38.1M 0.07%
5,200,000
+1,600,000
+44% +$12.3M
CNX icon
289
CNX Resources
CNX
$5.2B
$37.8M 0.07%
1,200,000
+1,004,545
+514% +$30.3M
ALL icon
290
Allstate
ALL
$69.6B
$37.6M 0.07%
181,819
-115,600
-39% -$22.5M
MNST icon
291
Monster Beverage
MNST
$92.1B
$37.4M 0.07%
639,022
-15,200
-2% -$792K
AVB icon
292
AvalonBay Communities
AVB
$26.6B
$36.4M 0.07%
169,738
-17,720
-9% -$3.85M
AME icon
293
Ametek
AME
$57.6B
$36.3M 0.07%
211,141
+47,000
+29% +$8.54M
CPAY icon
294
Corpay
CPAY
$26B
$36.1M 0.07%
103,658
+26,000
+33% +$9.39M
GH icon
295
Guardant Health
GH
$21.1B
$36.1M 0.07%
846,749
+566,949
+203% +$24.5M
EIX icon
296
Edison International
EIX
$25.9B
$35.5M 0.07%
603,304
+241,600
+67% +$13.9M
ZBRA icon
297
Zebra Technologies
ZBRA
$17.2B
$35.3M 0.07%
124,911
+41,700
+50% +$14.2M
NWSA icon
298
News Corp Class A
NWSA
$16B
$35.2M 0.07%
1,294,599
+233,820
+22% +$6.54M
AXON
299
Axon Enterprise
AXON
$42.4B
$34.8M 0.06%
66,100
-1,600
-2% -$936K
MSCI icon
300
MSCI
MSCI
$41.2B
$34.3M 0.06%
60,600
-8,900
-13% -$5.17M
10 11
12
13 14

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Adage Capital Partners held 986 positions worth $54B, down 5.6% from $57.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners's Q1 2025 filing shows 116 new, 314 increased, 359 reduced and 149 closed positions. Its largest new stake was Diamondback Energy: 485,503 shares worth $77.6M. The largest sale was Royalty Pharma, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2025 buy was Diamondback Energy: 485,503 shares worth $77.6M.
  • Adage Capital Partners added most to Hubbell in Q1 2025, an estimated $244M increase.
  • Adage Capital Partners's biggest Q1 2025 reduction was Royalty Pharma, cutting an estimated $340M.
  • Adage Capital Partners fully exited Geron in Q1 2025, selling an estimated $77.2M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $54B portfolio in Q1 2025.
  • Adage Capital Partners opened 116 new positions and closed 149 in Q1 2025.
  • Adage Capital Partners's portfolio value fell 5.6% quarter-over-quarter to $54B.

Based on Adage Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.